EMA — authorised 17 June 2011
- Status: approved
🇪🇺 Nulojix in European Union
EMA authorised Nulojix on 17 June 2011
Marketing authorisation
Nulojix in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Nulojix approved in European Union?
Yes. EMA authorised it on 17 June 2011.
Who is the marketing authorisation holder for Nulojix in European Union?
Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.